Karol Wróblewski

5PUBLICATIONS
12CO-AUTHORS
PharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Process control and simulationCheminformatics and quantitative structure-activity relationshipsToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 27, 2026
From Chromatographic Optimisation to Bioanalysis: HPLC System Comparison and HPLC-QTRAP-MS/MS Determination of Cariprazine and Lurasidone in Human Serum, Urine, and Saliva.

|Jan 22, 2024
Measurements of cadmium levels in relation to tobacco dependence and as a function of cytisine administration.

Karol Wróblewski, Julia Wojnicka, Piotr Tutka

|Mar 26, 2022
Development of the Validated Stability-Indicating Method for the Determination of Vortioxetine in Bulk and Pharmaceutical Formulation by HPLC-DAD, Stress Degradation Kinetics Studies and Detection of Degradation Products by LC-ESI-QTOF-MS.

Karol Wróblewski, Małgorzata Szultka-Młyńska, Daria Janiszewska

|Sep 03, 2020
Determination of Cytisine and N-Methylcytisine from Selected Plant Extracts by High-Performance Liquid Chromatography and Comparison of Their Cytotoxic Activity.

Anna Petruczynik, Karol Wróblewski, Justyna Misiurek

|May 31, 2020
Comparison of Various Chromatographic Systems for Identification of Vortioxetine in Bulk Drug Substance, Human Serum, Saliva, and Urine Samples by HPLC-DAD and LC-QTOF-MS.

Anna Petruczynik, Karol Wróblewski, Krzysztof Wojtanowski

Pageof 1

Frequent Collaborators

4 joint publications

Anna Petruczynik

1 joint publications

Tomasz Tuzimski

1 joint publications

Justyna Misiurek

1 joint publications

Tomasz Plech